Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00178633 · ClinicalTrials.gov registry record

Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery

A clinical trial of Obesity and Heart Failure, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
43
Enrollment target
1
Study location

NCT00178633: Completed study of Obesity and Heart Failure, sponsored by The University of Texas Health Science Center, Houston.

NCT00178633 is a study of Obesity and Heart Failure that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 43 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00178633, a study of Obesity and Heart Failure, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

An original cohort of 43 patients were recruited for analysis of anthropometrics, metabolic profile, skeletal muscle biopsy, echocardiogram at baseline, 3 months and 9 months post bariatric surgery. While all 43 patients reportedly completed 3 and 9 month evaluations, only 15 patients completed 24 month evaluations due to 28 patients unwilling to return. The overarching purpose appears to have been not only evaluation of weightloss, but normalization of metabolic profile over time.

Primary Outcome

Change in weight. Negative values represent weight loss.

Interventions

  • PROCEDURE Bariatric surgery

Study Locations (1)

Texas

  • University of Texas, Health Sciences Center Houston - Houston

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2004-05
Est. Completion 2008-08

What the finished NCT00178633 record still lists

NCT00178633 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Bariatric surgery is the first listed.

NCT00178633 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00178633 about?

NCT00178633 is a clinical study titled "Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery". An original cohort of 43 patients were recruited for analysis of anthropometrics, metabolic profile, skeletal muscle biopsy, echocardiogram at baseline, 3 months and 9 months post bariatric surgery. While all 43 patients reportedly completed 3 and 9 month evaluations, only 15 patients completed 24 m...

What is the current status of trial NCT00178633?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2004-05. Estimated completion is 2008-08.

What conditions does trial NCT00178633 study?

This clinical trial studies the following conditions: Obesity, Heart Failure, Diabetes, Insulin Resistance.

What interventions are being tested in trial NCT00178633?

The interventions under investigation include: Bariatric surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00178633?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00178633 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00178633's enrollment target sits among peer trials

43 767th of 1053 higher than 284 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00178633, the US trial registry maintained by the National Library of Medicine. NCT00178633 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.